Document is current
Any future updates will be listed below
-
Authors
Niemelä, Sakke https://orcid.org/0000-0002-8479-9096
Lempinen, Laura https://orcid.org/0000-0002-8568-1997
Löyttyniemi, Eliisa https://orcid.org/0000-0002-7278-6511
Oksi, Jarmo https://orcid.org/0000-0002-3331-997X
Jero, Jussi https://orcid.org/0000-0002-1945-4008
- License Information
-
More Information
Article History
Received: 20 September 2022
Accepted: 10 January 2023
First Online: 23 January 2023
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. The informed consent is waived by Ethics Committee of the Hospital District of Southwestern Finland in view of the retrospective nature. All experimental protocols were approved by Turku Clinical Research Center.
: Not applicable.
: J.O reports receiving compensations for lectures or advisory boards outside the submitted work from AstraZeneca, Biocodex, Gilead, GlaxoSmithKline, MSD-Finland, Orion, Pfizer, Roche, Rokotustutkimuskeskus, and for congress travel from UnimedicPharma. All other authors declare no conflicts of interest.
